Harmony Biosciences Holdings (HRMY) Gross Margin: 2020-2025
Historic Gross Margin for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to 75.09%.
- Harmony Biosciences Holdings' Gross Margin fell 192.00% to 75.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 77.70%, marking a year-over-year decrease of 96.00%. This contributed to the annual value of 78.06% for FY2024, which is 111.00% down from last year.
- As of Q3 2025, Harmony Biosciences Holdings' Gross Margin stood at 75.09%, which was down 7.26% from 80.97% recorded in Q2 2025.
- Harmony Biosciences Holdings' Gross Margin's 5-year high stood at 82.81% during Q2 2021, with a 5-year trough of 72.97% in Q4 2024.
- In the last 3 years, Harmony Biosciences Holdings' Gross Margin had a median value of 80.97% in 2025 and averaged 79.14%.
- Per our database at Business Quant, Harmony Biosciences Holdings' Gross Margin slumped by 467bps in 2023 and then surged by 46bps in 2025.
- Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Gross Margin stood at 80.47% in 2021, then tumbled by 142bps to 79.05% in 2022, then crashed by 467bps to 74.38% in 2023, then crashed by 141bps to 72.97% in 2024, then plummeted by 192bps to 75.09% in 2025.
- Its last three reported values are 75.09% in Q3 2025, 80.97% for Q2 2025, and 82.68% during Q1 2025.